Atrium Therapeutics Inc (RNA)
Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2013 | 12-2012 | |
| Sales | 6,787 | 2,319 | 379 | 0 | 0 |
| Gross Profit | 6,787 | 2,319 | 379 | 11,870 | N/A |
| Operating Expenses | 13,462 | 5,112 | 2,441 | 24,520 | 0 |
| Operating Income | -6,675 | -2,793 | -2,062 | -24,520 | N/A |
| Interest Expense | 209 | 7,387 | 718 | 0 | 0 |
| Other Income | -37,471 | -14,554 | -8,436 | 0 | 0 |
| Pre-tax Income | -44,355 | -24,734 | -11,216 | -24,520 | 0 |
| Net Income Continuous | -44,355 | -24,734 | -11,216 | -24,520 | N/A |
| Net Income | $-44,355 | $-24,734 | $-11,216 | $-24,520 | $N/A |
| EBITDA(a) | $-6,675 | $-2,793 | $-2,062 | $-22,930 | $N/A |